Exelixis, Inc. (LON:0IJO)
London · Delayed Price · Currency is GBP · Price in USD 37.77
+1.09 (2.98%)
At close: Aug 1, 2025
Exelixis Market Cap
Exelixis has a market cap or net worth of 7.57 billion as of August 1, 2025. Its market cap has increased by 47.98% in one year.
Market Cap
7.57B
Enterprise Value
6.66B
Revenue
1.63B
Ranking
n/a
PE Ratio
17.23
Stock Price
37.77
Market Cap Chart
Since April 11, 2000, Exelixis's market cap has increased from 409.19M to 7.57B, an increase of 1,750.60%. That is a compound annual growth rate of 12.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 7.37B | -2.93% |
| Dec 31, 2024 | 7.60B | 29.70% |
| Dec 29, 2023 | 5.86B | 36.40% |
| Dec 30, 2022 | 4.29B | 0.53% |
| Dec 31, 2021 | 4.27B | -6.34% |
| Dec 31, 2020 | 4.56B | 12.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 178.30B |
| GSK plc | 59.04B |
| Haleon | 32.79B |
| Smith & Nephew | 10.24B |
| ConvaTec Group | 4.72B |
| Hikma Pharmaceuticals | 4.40B |
| HUTCHMED (China) | 2.34B |
| Oxford Nanopore Technologies | 1.94B |